Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NPAT Inhibitors

NPAT (Nuclear Protein, Coactivator of Histone Transcription) inhibitors are a class of chemical compounds designed to target and inhibit the activity of NPAT, a key protein involved in the regulation of histone gene transcription. NPAT is a nuclear protein that functions primarily in cell cycle progression and chromatin organization, playing a crucial role in histone gene transcription during the S-phase of the cell cycle. It acts as a coactivator, coordinating the transcription of histones required for chromatin assembly and DNA replication. NPAT is associated with nuclear structures called Histone Locus Bodies (HLBs), where it regulates the transcription of histone gene clusters. The inhibition of NPAT leads to the disruption of histone mRNA synthesis, affecting chromatin structure and cellular processes such as DNA replication and cell division.

NPAT inhibitors generally work by binding to the NPAT protein or interfering with its associated signaling pathways, thereby preventing its interaction with other co-factors or its ability to promote histone transcription. Such inhibition disrupts the coordinated expression of histone genes, leading to downstream effects on chromatin organization and cellular replication. By targeting the NPAT pathway, these inhibitors provide valuable tools for studying the intricate regulation of cell cycle progression and chromatin dynamics. The molecular diversity of NPAT inhibitors can vary widely, encompassing small molecules, peptides, or other chemical scaffolds, each uniquely affecting NPAT activity or its interactions. These inhibitors serve as important research tools for understanding the regulation of histone gene transcription and the broader implications for cellular growth and chromatin function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

A cyclin-dependent kinase (CDK) inhibitor that can affect the cell cycle and potentially impact NPAT function.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Another CDK inhibitor, known to target various cyclin-dependent kinases involved in cell cycle regulation, potentially influencing NPAT activity.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

A PARP inhibitor, which, while primarily used in DNA repair pathways, could indirectly affect NPAT function due to its role in the S phase of the cell cycle.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor, which can alter chromatin structure and potentially impact NPAT-mediated histone transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Also a histone deacetylase inhibitor, it can indirectly affect NPAT activity by altering chromatin accessibility and histone modifications.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

A specific inhibitor of CDK4 and CDK6, which may indirectly impact NPAT's role in cell cycle progression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to 5-Azacytidine, it's a DNA methyltransferase inhibitor that may indirectly affect NPAT's function in histone gene transcription.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

An inhibitor of Topoisomerase I, impacting DNA replication and potentially influencing the activity of NPAT in the S phase.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can affect various cellular processes, including those regulated by NPAT.